Proteosome influenza vaccine: Began Phase I testing

Intellivax International Inc., Montreal, Quebec Product: Proteosome influenza vaccine Business: Infectious diseases Therapeutic category: Immune stimulation, Viral infection Target: Immune cells Descr...